Vimarsana
Biggest News Aggregation in the World

Daara Patel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daara Patel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daara Patel Today - Breaking & Trending Today

Drug firms move ministry over FDC ban, seek time to sell stock - Vimarsana News

Drug firms move ministry over FDC ban, seek time to sell stock

FDC drugs, which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio, were recently baned by Drug Controller General of India (DCGI).

Pharma industry and DoP to enhance stakeholder intervention for SPI Scheme - Vimarsana News

Pharma industry and DoP to enhance stakeholder intervention for SPI Scheme

Pharma industry and DoP to enhance stakeholder intervention for SPI Scheme

Firm linked to Gambia deaths failed to meet standards for other drugs four times in India this year - Vimarsana News

Firm linked to Gambia deaths failed to meet standards for other drugs four times in India this year

Meanwhile, the Food and Drug Administration in Haryana said it was preparing to test samples of the four syrups, which were made for export.

Source: scroll.in
Indian Pharma - Global Health Care honors IDMA's Diamond Jubilee celebration - Vimarsana News

Indian Pharma - Global Health Care honors IDMA's Diamond Jubilee celebration

Mumbai (Maharashtra) [India], April 6 (ANI/Nova Realtime Solutions LLP): On the occasion of the Indian Drug Manufacturers' Association (IDMA)'s 60th-year celebration commemorating April 14-15, 2022, the entire theme revolves around 'Indian Pharma - Global Healthcare.' IDMA greets all to be a part of history, enjoy the present and progress in the future.

IDMA adds voice to call for voluntary licences on vaccines - The Hindu BusinessLine - Vimarsana News

IDMA adds voice to call for voluntary licences on vaccines - The Hindu BusinessLine

‘Other vaccine developers must transfer technology to Indian companies against reasonable royalties’